FDA Will Continue to Study BPA; Has No Plans to Amend Position That Plastics Chemical Is Safe

The Food and Drug Administration, criticized by its own scientific advisers for ignoring available data about health risks posed by a chemical found in everyday plastic, said yesterday it has no plans to amend its position on the substance but will continue to study it.